These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5288233)

  • 1. Endometrial effects of Ovral.
    Roland M
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:89-93. PubMed ID: 5288233
    [No Abstract]   [Full Text] [Related]  

  • 2. Fertility control with Ovral. A clinical review.
    Laurie RE; Lewis ET
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:95-107. PubMed ID: 4256548
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
    Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
    [No Abstract]   [Full Text] [Related]  

  • 4. Post coital contraception--A pilot study.
    Yuzpe AA; Thurlow HJ; Ramzy I; Leyshon JI
    J Reprod Med; 1974 Aug; 13(2):53-8. PubMed ID: 4844513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low-dosage contraceptive in Public Health clinics.
    Andelman MB; Zackler J; Walters JE
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:117-24. PubMed ID: 5288230
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis.
    Givens JR; Fort AT; Leigh JH
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:69-76. PubMed ID: 4330931
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of menstruation and Microgynon 30 on sway behaviour.
    Graham SE; Thornton H; Atha J
    Agressologie; 1978; 19(B):55-6. PubMed ID: 727358
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endometrial cytological and cytometric characteristics in normal conditions].
    Minucci D; Rabasso A; Tessari G; Callegari G; Cinel A
    Minerva Ginecol; 1980 Apr; 32(4):283-6. PubMed ID: 7383436
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
    Gerhards E; Lachnit U; Gaude R; Schillinger E
    Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
    Gaudefroy M; Corette L; Coliche D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
    [No Abstract]   [Full Text] [Related]  

  • 11. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo.
    Cullberg J
    Acta Psychiatr Scand Suppl; 1972; 236():1-86. PubMed ID: 4565340
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a synthetic estrogen-progestogen agent on urinary gonadotropin levels of FSA and LH using a radioimmunologic method.
    Forleo R; Vegna G; Pala A
    Acta Eur Fertil; 1972 Jun; 3(2):159-76. PubMed ID: 4679575
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphological and histochemical study of the endometrical effects of ovral in the baboon.
    Dollar JR; Boots LR; Santolucito KA; Bagwell JN
    Cell Tissue Res; 1981; 217(3):611-24. PubMed ID: 6265093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous glucose tolerance, insulin response, fasting blood glucose and serum insulin during short-term administration of a combined oral contraceptive.
    Nielsen FH
    Acta Obstet Gynecol Scand; 1972; 51(4):319-24. PubMed ID: 4642718
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial with a combination of 150 mcg of d-norgestrel and 30 mcg of ethinylestradiol. Its metabolic effects].
    Moggia AV; Koremblit E; Beauquis A
    Obstet Ginecol Lat Am; 1976; 34(11-12):384-97. PubMed ID: 801618
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum triglyceride in women with and without a predisposition to diabetes during short-term administration of a combined oral contraception.
    Nelson FH
    Acta Obstet Gynecol Scand; 1974; 53(1):13-9. PubMed ID: 4817622
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
    Lévrier M
    Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
    [No Abstract]   [Full Text] [Related]  

  • 18. Norgestrel and ethynyl estradiol: a new low-dosage oral agent for fertility control.
    Rice-Wray E; Avila C; Gutiérrez J
    Obstet Gynecol; 1968 Mar; 31(3):368-74. PubMed ID: 5639191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practical experience with a new contraceptive of the modified sequential type].
    Welti H
    Rev Med Suisse Romande; 1972 Oct; 92(10):785-95. PubMed ID: 4660891
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endometrial interference of synthetic estrogens in fertility regulation.Is it necessary to interfere with the antiovulatory mechanism at the central nervous system level in order to obtain contraception?].
    Sojo Aranda QI; Rojas T; Cortés-Gallegos V
    Ginecol Obstet Mex; 1997 Oct; 65():449-51. PubMed ID: 9432479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.